Background: Cancer development involves alterations in key cellular pathways, with aspartate β-hydroxylase (ASPH) emerging as an important player in tumorigenesis. ASPH is upregulated in various cancer types, where it promotes cancer progression mainly by regulating the Notch1 and SRC pathways. Methods: This study explored the responses of various human cervical, pharyngeal, and breast tumor cell lines to second- and third-generation ASPH inhibitors (MO-I-1151 and MO-I-1182) using proliferation, migration, and invasion assays; western blotting; and cell cycle analysis. Results: ASPH inhibition significantly reduced cell proliferation, migration, and invasion and disrupted both the canonical and noncanonical Notch1 pathways. The noncanonical pathway was particularly mediated by AKT signaling. Cell cycle analysis revealed a marked reduction in cyclin D1 expression, further confirming the inhibitory effect of ASPH inhibitors on cell proliferation. Additional analysis revealed G0/G1 arrest and restricted progression into S phase, highlighting the regulatory impact of ASPH inhibitors on the cell cycle. Furthermore, ASPH inhibition induced distinctive alterations in nuclear morphology. The high heterogeneity in the responses of individual tumor cell lines to ASPH inhibitors, both quantitatively and qualitatively, underscores the complex network of mechanisms that are regulated by ASPH and influence the efficacy of ASPH inhibition. The effects of ASPH inhibitors on Notch1 pathway activity, cyclin D1 expression, and nuclear morphology contribute to the understanding of the multifaceted effects of these inhibitors on cancer cell behavior. Conclusion: This study not only suggests that ASPH inhibitors are effective against tumor cell progression, in part through the induction of cell cycle arrest, but also highlights the diverse and heterogeneous effects of these inhibitors on the behavior of tumor cells of different origins.

Department of Genetics and Microbiology Faculty of Science Charles University BIOCEV Vestec Czech Republic

Department of Pharmaceutical Sciences College of Pharmacy Glendale Midwestern University Glendale AZ USA

Zobrazit více v PubMed

Greve JM, Pinkham AM, Cowan JA. Human aspartyl (asparaginyl) hydroxylase. A multifaceted enzyme with broad intra- and extra-cellular activity. Metallomics. 2021;13:mfab044. PubMed

Dinchuk JE, Henderson NL, Burn TC. et al. Aspartyl β-hydroxylase (Asph) and an evolutionarily conserved isoform of Asph missing the catalytic domain share exons with junctin. J Biol Chem. 2000;275:39543–54. PubMed

Kanwal M, Smahel M, Olsen M, Smahelova J, Tachezy R. Aspartate β-hydroxylase as a target for cancer therapy. J Exp Clin Cancer Res. 2020;39:163. PubMed PMC

Engel J. EGF-like domains in extracellular matrix proteins: Localized signals for growth and differentiation? FEBS Lett. 1989;251:1–7. PubMed

Lavaissiere L, Jia S, Nishiyama M. et al. Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma. J Clin Invest. 1996;98:1313–23. PubMed PMC

Sturla L-M, Tong M, Hebda N. et al. Aspartate-β-hydroxylase (ASPH): a potential therapeutic target in human malignant gliomas. Heliyon. 2016;2:e00203. PubMed PMC

Nagaoka K, Bai X, Ogawa K. et al. Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma. Cancer Lett. 2019;449:87–98. PubMed PMC

Aihara A, Huang C-K, Olsen MJ. et al. A cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma. Hepatology. 2014;60:1302–13. PubMed PMC

Gridley T. Notch signaling and inherited disease syndromes. Hum Mol Genet. 2003;12:R9–13. PubMed

Dong X, Lin Q, Aihara A. et al. Aspartate β-hydroxylase expression promotes a malignant pancreatic cellular phenotype. Oncotarget. 2014;6:1231–48. PubMed PMC

Lin Q, Chen X, Meng F. et al. Asph-notch axis guided exosomal delivery of prometastatic secretome renders breast cancer multi-organ metastasis. Mol Cancer. 2019;18:156. PubMed PMC

Zhou B, Lin W, Long Y. et al. Notch signaling pathway: architecture, disease, and therapeutics. Signal Transduct Target Ther. 2022;7:1–33. PubMed PMC

Brewitz L, Tumber A, Thalhammer A, Salah E, Christensen KE, Schofield CJ. Synthesis of novel pyridine-carboxylates as small-molecule inhibitors of human aspartate/asparagine-β-hydroxylase. ChemMedChem. 2020;15:1139–49. PubMed PMC

Huang C-K, Iwagami Y, Aihara A. et al. Anti-tumor effects of second generation β-hydroxylase inhibitors on cholangiocarcinoma development and progression. PLOS ONE. 2016;11:e0150336. PubMed PMC

Ogawa K, Lin Q, Li L. et al. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway. J Hematol Oncol. 2019;12:144. PubMed PMC

Iwagami Y, Huang C-K, Olsen MJ. et al. Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma. Hepatology. 2016;63:1213–26. PubMed PMC

Nagaoka K, Ogawa K, Ji C. et al. Targeting aspartate beta-hydroxylase with the small molecule inhibitor MO-I-1182 suppresses cholangiocarcinoma metastasis. Dig Dis Sci. 2021;66:1080–9. PubMed

Palomero T, Lim WK, Odom DT. et al. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci U S A. 2006;103:18261–6. PubMed PMC

Lahousse SA, Carter JJ, Xu XJ, Wands JR, de la Monte SM. Differential growth factor regulation of aspartyl-(asparaginyl)-β-hydroxylase family genes in SH-Sy5y human neuroblastoma cells. BMC Cell Biol. 2006;7:41. PubMed PMC

Oh S, Kim H, Nam K, Shin I. Silencing of Glut1 induces chemoresistance via modulation of Akt/GSK-3β/β-catenin/survivin signaling pathway in breast cancer cells. Arch Biochem Biophys. 2017;636:110–22. PubMed

Barboro P, Benelli R, Tosetti F. et al. Aspartate β-hydroxylase targeting in castration-resistant prostate cancer modulates the NOTCH/HIF1α/GSK3β crosstalk. Carcinogenesis. 2020;41:1246–52. PubMed

Peng H, Guo Q, Xiao Y. et al. ASPH regulates osteogenic differentiation and cellular senescence of BMSCs. Front Cell Dev Biol. 2020;8:872. PubMed PMC

Zou Q, Hou Y, Wang H. et al. Hydroxylase activity of ASPH promotes hepatocellular carcinoma metastasis through epithelial-to-mesenchymal transition pathway. EBioMedicine. 2018;31:287–98. PubMed PMC

Klein EA, Assoian RK. Transcriptional regulation of the cyclin D1 gene at a glance. J Cell Sci. 2008;121:3853–7. PubMed PMC

Gan X, Li S, Wang Y. et al. Aspartate β-hydroxylase serves as a prognostic biomarker for neoadjuvant chemotherapy in gastric cancer. Int J Mol Sci. 2023;24:5482. PubMed PMC

Yang H, Song K, Xue T. et al. The distribution and expression profiles of human Aspartyl/Asparaginyl beta-hydroxylase in tumor cell lines and human tissues. Oncol Rep. 2010;24:1257–64. PubMed

Cantarini MC, Monte SM de la, Pang M. et al. Aspartyl-asparagyl β hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms. Hepatology. 2006;44:446–57. PubMed

Gundogan F, Elwood G, Longato L. et al. Impaired placentation in fetal alcohol syndrome. Placenta. 2008;29:148–57. PubMed PMC

Benelli R, Costa D, Mastracci L. et al. Aspartate-β-hydroxylase: a promising target to limit the local invasiveness of colorectal cancer. Cancers. 2020;12:971. PubMed PMC

Iso T, Kedes L, Hamamori Y. HES and HERP families: Multiple effectors of the notch signaling pathway. J Cell Physiol. 2003;194:237–55. PubMed

Sepe PS, Lahousse SA, Gemelli B. et al. Role of the aspartyl-asparaginyl-β-hydroxylase gene in neuroblastoma cell motility. Lab Invest. 2002;82:881–91. PubMed

Lawton M, Tong M, Gundogan F, Wands JR, de la Monte SM. Aspartyl-(asparaginyl) beta-hydroxylase, hypoxia-inducible factor-alpha and Notch cross-talk in regulating neuronal motility. Oxid Med Cell Longev. 2010;3:347–56. PubMed PMC

Sen P, Ghosh SS. The intricate Notch signaling dynamics in therapeutic realms of cancer. ACS Pharmacol Transl Sci. 2023;6:651–70. PubMed PMC

Meurette O, Stylianou S, Rock R, Collu GM, Gilmore AP, Brennan K. Notch activation induces Akt signaling via an autocrine loop to prevent apoptosis in breast epithelial cells. Cancer Res. 2009;69:5015–22. PubMed

Yao W-F, Liu J-W, Huang D-S. MiR-200a inhibits cell proliferation and EMT by down-regulating the ASPH expression levels and affecting ERK and PI3K/Akt pathways in human hepatoma cells. Am J Transl Res. 2018;10:1117. PubMed PMC

Konietzko U, Goodger ZV, Meyer M. et al. Co-localization of the amyloid precursor protein and Notch intracellular domains in nuclear transcription factories. Neurobiol Aging. 2010;31:58–73. PubMed PMC

Hooper C, Chapple JP, Lovestone S, Killick R. The Notch-1 intracellular domain is found in sub-nuclear bodies in SH-SY5Y neuroblastomas and in primary cortical neurons. Neurosci Lett. 2007;415:135–9. PubMed PMC

Ching RW, Dellaire G, Eskiw CH, Bazett-Jones DP. PML bodies: a meeting place for genomic loci? J Cell Sci. 2005;118:847–54. PubMed

Filgueiras M de C, Morrot A, Soares PMG, Costa ML, Mermelstein C. Effects of 5-fluorouracil in nuclear and cellular morphology, proliferation, cell cycle, apoptosis, cytoskeletal and caveolar distribution in primary cultures of smooth muscle cells. PLOS ONE. 2013;8:e63177. PubMed PMC

Gomes DL, Telles CBS, Costa MSSP. et al. Methanolic extracts from brown seaweeds Dictyota cilliolata and Dictiota menstrualis induce apoptosis in human cervical adenocarcinoma HeLa cells. Molecules. 2015;20:6573–91. PubMed PMC

Palanivel K, Kanimozhi V, Kadalmani B, Akbarsha MA. Verrucarin A, a protein synthesis inhibitor, induces growth inhibition and apoptosis in breast cancer cell lines MDA-MB-231 and T47D. Biotechnol Lett. 2013;35:1395–403. PubMed

Lin Q, Chen X, Meng F. et al. Multi-organ metastasis as destination for breast cancer cells guided by biomechanical architecture. Am J Cancer Res. 2021;11:2537–67. PubMed PMC

Cohen B, Shimizu M, Izrailit J. et al. Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer. Breast Cancer Res Treat. 2010;123:113–24. PubMed

Mukherji A, Janbandhu VC, Kumar V. GSK-3β-dependent destabilization of cyclin D1 mediates replicational stress-induced arrest of cell cycle. FEBS Lett. 2008;582:1111–6. PubMed

Sugimachi K, Aishima S, Taguchi K. et al. The role of overexpression and gene amplification of cyclin D1 in intrahepatic cholangiocarcinoma. J Hepatol. 2001;35:74–9. PubMed

Zhou Q, Lin J, Yan Y. et al. INPP5F translocates into cytoplasm and interacts with ASPH to promote tumor growth in hepatocellular carcinoma. J Exp Clin Cancer Res. 2022;41:13. PubMed PMC

Kanwal M, Smahelova J, Ciharova B. et al. Aspartate β-hydroxylase regulates expression of Ly6 genes. J Cancer. 2024;15:1138–52. PubMed PMC